Cargando…
Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease
INTRODUCTION: Up to 40% of Parkinson’s disease patients taking dopamine agonist medication develop impulse control behaviors which can have severe negative consequences. The current study aimed to utilize dopamine genetics to identify patients most at risk of developing these behaviors. METHODS: Dem...
Autores principales: | Hall, Alison, Weaver, Samuel R., Compton, Lindsey J., Byblow, Winston D., Jenkinson, Ned, MacDonald, Hayley J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569744/ https://www.ncbi.nlm.nih.gov/pubmed/34765965 http://dx.doi.org/10.1016/j.prdoa.2021.100113 |
Ejemplares similares
-
Performance on the balloon analogue risk task and anticipatory response inhibition task is associated with severity of impulse control behaviours in people with Parkinson’s disease
por: Hall, Alison, et al.
Publicado: (2023) -
Exploring stop signal reaction time over two sessions of the anticipatory response inhibition task
por: Hall, Alison, et al.
Publicado: (2022) -
Memory deficits in Parkinson’s disease are associated with reduced beta power modulation
por: MacDonald, Hayley J, et al.
Publicado: (2019) -
Dopamine and reward hypersensitivity in Parkinson’s disease with impulse control disorder
por: Drew, Daniel S, et al.
Publicado: (2020) -
Motivational and myopic mechanisms underlying dopamine medication-induced impulsive-compulsive behaviors in Parkinson's disease
por: Dawson, Andrew, et al.
Publicado: (2023)